ArticleBreast (Edinburgh, Scotland)2021

Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancer.

Pietro Lapidari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.